+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

Schizophrenia - Pipeline Insight, 2024 - Product Thumbnail Image

Schizophrenia - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 - Product Thumbnail Image

Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Anorexia Nervosa - Pipeline Insight, 2024 - Product Thumbnail Image

Anorexia Nervosa - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
Sigma-1 receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Sigma-1 receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
mGlu 2/3 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

mGlu 2/3 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
mGlu 2/3/5 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

mGlu 2/3/5 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Serotonin Transporter Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin Transporter Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
D Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

D Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Sigma Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Sigma Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Serotonin receptor 2 angonist - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin receptor 2 angonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
Panic disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Panic disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Acute Social Anxiety Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Social Anxiety Disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024 - Product Thumbnail Image

Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2024 - Product Thumbnail Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more